?
z.B. 0-20
?
z.B. 0-15
?
z.B. 0-5
?
z.B. 0-3
Aktien Screener: Pharmazeutika
Filter & Suche
496 Ergebnisse (1 aktive Filter)
Die Kennzahlen-Filter werden aktiviert, sobald die vollständige Liste geladen ist.
Suchergebnisse
496 Unternehmen gefunden • Seite 6 von 20
? | ? | ? | ? | ? | ? | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Kyowa Kirin Co. Ltd | 61.6 | Arzneimittel (Pharmazeutisch) | Japan | 8.1 Mrd. USD | 15.74 | 12.39 | 2.42 | 1.41 | ▲ 9.33% | ▲ 7.37% | 2.87% | ▲ 0.56% | - | 13.49% | ▼ -0.41% | 20.59% | ▲ 0.43% | 11.86% | ▼ -2.68% | 7 / 9 | 7,97 | 25-fach | 33 / 100 | −3,0 / 100 | −2,48 |
 | Celltrion Inc | 61.6 | Arzneimittel (Biotechnologie) | Südkorea | 32.6 Mrd. USD | 27.63 | 79.37 | 8.89 | 2.43 | ▲ 17.62% | ▲ 14.74% | 0.38% | - | 2 Jahre | 24.74% | ▼ -2.28% | 27.78% | ▼ -3.81% | 7.55% | ▼ -1.70% | 6 / 9 | 5,16 | 16-fach | 11 / 100 | 1,7 / 100 | −2,16 |
 | Zhejiang Ausun Pharmaceutical Co Ltd | 61.5 | Arzneimittel (Biotechnologie) | China | 0.9 Mrd. USD | 74.15 | 236.70 | 7.72 | 2.52 | ▲ 14.14% | ▲ 8.50% | 0.88% | - | 3 Jahre | 16.47% | ▼ -2.31% | 17.49% | ▼ -2.46% | 6.57% | ▲ 8.94% | 6 / 9 | 6,49 | 28-fach | 14 / 100 | −0,8 / 100 | −2,75 |
| Hanmi Science | 61.0 | Arzneimittel (Pharmazeutisch) | Südkorea | 2.1 Mrd. USD | 18.95 | 109.17 | 2.06 | 2.69 | ▲ 9.62% | ▲ 39.26% | 0.72% | - | - | 8.72% | ▲ 0.64% | 4.20% | ▲ 0.26% | 1.97% | ▲ 0.69% | 7 / 9 | 3,96 | 11-fach | 21 / 100 | 4,7 / 100 | −2,28 |
 | Yunnan Baiyao Group Co Ltd | 60.9 | Arzneimittel (Pharmazeutisch) | China | 14.2 Mrd. USD | 18.09 | 443.56 | 2.26 | 2.30 | ▲ 4.70% | ▼ -1.35% | 2.99% | - | - | 12.51% | ▲ 1.32% | 12.21% | ▲ 1.03% | 10.00% | ▼ -0.43% | 7 / 9 | 7,39 | > 50-fach | 22 / 100 | 1,0 / 100 | −3,13 |
 | UCB SA | 60.8 | Arzneimittel (Pharmazeutisch) | Belgien | 57.7 Mrd. USD | 23.51 | 34.57 | 6.05 | 4.43 | ▲ 7.68% | ▲ 16.31% | 0.54% | ▲ 2.69% | 16 Jahre | 20.13% | ▲ 1.34% | 15.06% | ▲ 0.47% | 24.31% | ▲ 1.33% | 8 / 9 | 4,44 | 9-fach | 30 / 100 | −3,3 / 100 | −2,38 |
| Yili Chuanning Biotechnology Co. Ltd. A | 60.6 | Arzneimittel (Biotechnologie) | China | 2.4 Mrd. USD | 32.75 | - | 3.95 | 2.00 | - | - | 2.40% | - | - | 16.66% | ▲ 4.00% | 22.11% | ▲ 3.09% | 9.79% | ▼ -1.34% | 5 / 9 | 6,51 | 22-fach | 13 / 100 | 2,1 / 100 | −1,99 |
 | Innoviva Inc | 60.5 | Arzneimittel (Pharmazeutisch) | USA | 1.5 Mrd. USD | 4.27 | 8.10 | 3.44 | 1.24 | ▲ 4.77% | ▲ 3.86% | - | - | - | 63.78% | ▼ -6.62% | 38.52% | ▼ -13.04% | 43.85% | ▼ -10.56% | 6 / 9 | 7,33 | 11-fach | 19 / 100 | 4,5 / 100 | −2,26 |
 | MannKind Corp | 60.2 | Arzneimittel (Biotechnologie) | USA | 1.1 Mrd. USD | - | - | 2.80 | -16.41 | ▲ 39.89% | - | - | - | - | 1.68% | ▲ 31.52% | 11.12% | ▲ 23.66% | 3.92% | ▲ 30.18% | 6 / 9 | −11,95 | 1-fach | 36 / 100 | −1,6 / 100 | 0,71 |
 | Royalty Pharma Plc | 60.1 | Arzneimittel (Pharmazeutisch) | USA | 37.5 Mrd. USD | 45.94 | 12.59 | 14.77 | 5.48 | ▲ 2.30% | ▼ -4.59% | 1.45% | ▲ 6.69% | 5 Jahre | 32.42% | ▲ 4.67% | 65.58% | ▲ 4.95% | 104.69% | ▲ 15.09% | 5 / 9 | 1,82 | 7-fach | 15 / 100 | −10,5 / 100 | 5,50 |
| Zhejiang Wolwo Bio-Pharmaceutical Co Ltd | 60.0 | Arzneimittel (Pharmazeutisch) | China | 1.7 Mrd. USD | 25.97 | - | 9.92 | 3.79 | ▲ 10.80% | ▲ 6.47% | 1.18% | - | 1 Jahre | 35.86% | ▼ -1.66% | 39.01% | ▼ -2.36% | 28.60% | ▼ -0.54% | 9 / 9 | 21,60 | > 50-fach | 36 / 100 | −1,5 / 100 | −3,05 |
| Tibet Cheezheng Tibetan Medicine Co Ltd | 59.6 | Arzneimittel (Pharmazeutisch) | China | 1.6 Mrd. USD | 17.07 | - | 4.81 | 2.15 | ▲ 10.22% | ▲ 9.85% | 3.40% | ▼ -7.52% | - | 26.75% | ▼ -2.56% | 31.58% | ▼ -2.35% | 23.87% | ▼ -4.70% | 7 / 9 | 7,17 | 13-fach | 35 / 100 | −1,2 / 100 | −4,11 |
 | TELIX Pharmaceuticals Ltd | 59.5 | Arzneimittel (Biotechnologie) | Australien | 3.2 Mrd. USD | 98.10 | - | 3.63 | 6.59 | ▲ 174.79% | ▼ -30.80% | - | - | - | -0.87% | ▲ 218.94% | 2.21% | ▲ 219.98% | -6.87% | ▲ 163.34% | 2 / 9 | 0,87 | 2-fach | 37 / 100 | 0,9 / 100 | −2,09 |
| Changzhou Qianhong Biopharma Co Ltd | 59.3 | Arzneimittel (Pharmazeutisch) | China | 1.1 Mrd. USD | 25.02 | - | 5.00 | 2.68 | ▼ -1.18% | - | 2.60% | ▲ 4.56% | - | 25.38% | ▲ 4.07% | 21.16% | ▲ 3.03% | 13.99% | ▲ 6.05% | 6 / 9 | 14,94 | > 50-fach | 30 / 100 | 1,2 / 100 | −2,89 |
 | Kuros Biosciences AG | 59.2 | Arzneimittel (Biotechnologie) | Schweiz | 1.0 Mrd. USD | 103.18 | - | 5.97 | 11.51 | ▲ 97.48% | - | - | - | - | 2.10% | ▲ 18.96% | 6.04% | ▲ 20.71% | -1.98% | ▲ 12.62% | 5 / 9 | 3,08 | −11,5-fach | 98 / 100 | 2,7 / 100 | −1,71 |
 | Pacific Shuanglin Bio pharmacy Co Ltd | 58.9 | Arzneimittel (Pharmazeutisch) | China | 1.3 Mrd. USD | 41.97 | - | 3.69 | 1.12 | ▲ 20.18% | ▲ 17.66% | 1.59% | - | - | 15.93% | ▼ -0.42% | 22.28% | ▲ 0.34% | -20.87% | ▼ -6.36% | 2 / 9 | 9,13 | > 50-fach | 12 / 100 | 6,7 / 100 | −1,94 |
| Zhejiang Jiuzhou Pharm Co Ltd | 58.9 | Arzneimittel (Pharmazeutisch) | China | 2.0 Mrd. USD | 21.99 | - | 2.49 | 1.48 | ▲ 15.78% | ▲ 13.92% | 1.30% | - | 1 Jahre | 13.25% | ▼ -0.99% | 22.39% | ▲ 0.15% | 21.13% | ▲ 3.00% | 9 / 9 | 9,14 | > 50-fach | 19 / 100 | −10,4 / 100 | −3,04 |
 | Bristol-Myers Squibb Company | 58.7 | Arzneimittel (Pharmazeutisch) | USA | 125.4 Mrd. USD | 13.51 | 10.96 | 2.55 | 5.62 | ▲ 2.54% | - | 4.16% | - | 4 Jahre | 14.64% | ▼ -3.31% | 28.48% | ▲ 1.26% | 26.65% | ▼ -0.94% | 8 / 9 | 2,16 | 3-fach | 38 / 100 | −7,9 / 100 | −2,73 |
 | Xeris Pharmaceuticals Inc | 58.5 | Arzneimittel (Pharmazeutisch) | USA | 2.0 Mrd. USD | - | 35.39 | 5.84 | -201.35 | ▲ 154.71% | - | - | - | - | 0.19% | ▲ 55.42% | 8.53% | ▲ 53.92% | 9.57% | ▲ 48.40% | 7 / 9 | −2,91 | −0,4-fach | 62 / 100 | −7,3 / 100 | −2,57 |
 | Ligand Pharmaceuticals Incorporated | 58.5 | Arzneimittel (Pharmazeutisch) | USA | 6.4 Mrd. USD | 32.22 | 48.38 | 21.87 | 6.57 | ▲ 10.39% | - | - | - | - | 46.42% | ▲ 5.98% | 17.61% | ▼ -6.59% | 18.24% | ▼ -3.63% | 7 / 9 | 7,28 | 28-fach | 17 / 100 | 4,8 / 100 | −1,79 |
| Anhui Huaheng Biotechnology Co. Ltd. A | 58.4 | Arzneimittel (Biotechnologie) | China | 0.6 Mrd. USD | 40.32 | - | 1.24 | 1.39 | ▲ 42.49% | ▲ 1.80% | 1.02% | ▼ -0.04% | - | 4.63% | ▼ -3.99% | 4.53% | ▼ -4.50% | -18.60% | ▼ -4.56% | 5 / 9 | 1,87 | 9-fach | 11 / 100 | 0,5 / 100 | −1,88 |
 | HUTCHMED DRC | 58.3 | Arzneimittel (Pharmazeutisch) | Hong Kong | 2.3 Mrd. USD | 129.46 | 232.71 | 4.22 | 1.84 | ▲ 19.22% | - | - | - | - | 83.30% | ▲ 36.65% | -9.95% | ▲ 34.23% | -16.15% | ▲ 16.06% | 5 / 9 | 8,63 | > 50-fach | 12 / 100 | 30,0 / 100 | −1,19 |
 | Genmab A/S | 57.9 | Arzneimittel (Biotechnologie) | Dänemark | 35.6 Mrd. USD | 45.25 | 41.00 | 8.61 | 5.99 | ▼ -18.13% | ▼ -26.68% | - | - | - | 27.10% | ▼ -1.84% | 28.63% | ▼ -2.33% | 32.05% | ▲ 2.80% | 5 / 9 | 3,32 | > 50-fach | 27 / 100 | −1,7 / 100 | −3,92 |
| Zhangzhou Pientzehuang Pharmaceutical Co Ltd | 57.7 | Arzneimittel (Pharmazeutisch) | China | 11.5 Mrd. USD | 42.48 | - | 9.38 | 5.26 | ▲ 6.69% | ▲ 5.25% | 2.07% | - | 5 Jahre | 23.98% | ▼ -1.35% | 25.00% | ▼ -2.28% | -2.92% | ▼ -8.98% | 5 / 9 | 12,52 | > 50-fach | 19 / 100 | 12,2 / 100 | −2,38 |
 | Amphastar P | 57.5 | Arzneimittel (Pharmazeutisch) | USA | 1.1 Mrd. USD | 14.26 | 7.33 | 1.53 | 1.46 | ▲ 15.53% | ▲ 133.84% | - | - | - | 13.63% | ▲ 0.24% | 19.50% | ▲ 1.36% | 16.84% | ▲ 1.19% | 6 / 9 | 4,86 | 7-fach | 22 / 100 | −3,6 / 100 | −2,70 |
